Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

NCT00003405 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No enrollment

Conditions

Leukemia

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: amifostine trihydrate
DRUG: bromodeoxyuridine
DRUG: cytarabine
DRUG: idarubicin
DRUG: idoxuridine
DRUG: isotretinoin
DRUG: mitoxantrone hydrochloride

Sponsor

Rush University Medical Center

Collaborators

[object Object]